Quick Answer
Exousia Bio, Inc. reported Gross Profit of -$3.5 thousand for the year ending 2025.
- Exousia Bio, Inc. showed a decrease of -291.0% in Gross Profit from 2024 to 2025.
- This data is from Exousia Bio, Inc.'s annual report (Form 10-K), filed with the SEC on October 17, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $0.00 | Q3 2022: $0.00 | Q4 2022: $0.00 | Q1 2023: $0.00 | Q3 2023: $0.00 | Q4 2023: $3.9 thousand | Q1 2024: $3.9 thousand | Q3 2024: $3.8 thousand | Q4 2024: $0.00 | Q1 2025: $0.00 | Q3 2025: $0.00 | Q4 2025: -$62.1 thousand.
- Historical annual values: Fiscal year 2025: -$3.5 thousand | Fiscal year 2024: $1.8 thousand | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: